rs1057519373
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 6P and 1B. PM1PP3_StrongBS2_Supporting
The NM_000216.4(ANOS1):c.404C>T(p.Pro135Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000141 in 1,209,576 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000216.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANOS1 | NM_000216.4 | c.404C>T | p.Pro135Leu | missense_variant | 4/14 | ENST00000262648.8 | NP_000207.2 | |
ANOS1 | XM_005274501.5 | c.404C>T | p.Pro135Leu | missense_variant | 4/9 | XP_005274558.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANOS1 | ENST00000262648.8 | c.404C>T | p.Pro135Leu | missense_variant | 4/14 | 1 | NM_000216.4 | ENSP00000262648.3 |
Frequencies
GnomAD3 genomes AF: 0.0000448 AC: 5AN: 111729Hom.: 0 Cov.: 23 AF XY: 0.0000885 AC XY: 3AN XY: 33917
GnomAD3 exomes AF: 0.00000547 AC: 1AN: 182945Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67481
GnomAD4 exome AF: 0.0000109 AC: 12AN: 1097847Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 6AN XY: 363219
GnomAD4 genome AF: 0.0000448 AC: 5AN: 111729Hom.: 0 Cov.: 23 AF XY: 0.0000885 AC XY: 3AN XY: 33917
ClinVar
Submissions by phenotype
Hypogonadotropic hypogonadism 1 with or without anosmia Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 25, 2022 | - - |
Uncertain significance, criteria provided, single submitter | research | Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 11, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ANOS1 protein function. ClinVar contains an entry for this variant (Variation ID: 224351). This variant has not been reported in the literature in individuals affected with ANOS1-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.001%), including at least one homozygous and/or hemizygous individual. This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 135 of the ANOS1 protein (p.Pro135Leu). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at